BeiGene Ltd. ADR (B1ME34)
Market Closed
18 Jun, 19:55
B3 B3 Primary R$
56. 20
+2.15
+3.9778%
R$
161.23B Market Cap
- P/E Ratio
- Div Yield
3 Volume
-5.11 Eps
R$ 54.05
Previous Close Want to track B1ME34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BeiGene Ltd. ADR (B1ME34) Statistics
Valuation metrics
Market Cap 161.23B
Enterprise value 436.83B
Trailing P/E (ttm) 71.45
Forward P/E -
PEG ratio -
Price/Sales (ttm) 28.09
Price/Book (mrq) 0.29
Enterprise Value/Revenue 15.02
Enterprise Value/EBITDA 104.43
Overview
Shares outstanding 1.45B
Float 1.01B
Shares short -
% Held by insiders -
% Held by institutions 0.01%
Average volume (10 days) 16
Average volume (90 days) 8
Price summary
52-Week low 52.6
52-Week high 72.73
Beta 0.5
50-Day moving average 61.66
200-Day moving average 67.7
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.09%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.12%
Income Statement
Revenue (ttm) 29.09B
Revenue per share (ttm) 52.14
Quarterly revenue growth (yoy) 0.35%
Gross profit (ttm) 25.69B
EBITDA 906.11M
Net income to common (ttm) 2.6B
Diluted EPS (ttm) 0.87
Quarterly earnings growth (yoy) 178.02%
Balance Sheet
Total cash (mrq) 24.28B
Total cash per share (mrq) 3.31
Total debt (mrq) 5.82B
Total Debt/Equity (mrq) 24.14
Current ratio (mrq) 3.64%
Book value per share (mrq) 215.41
Cash Flow
Cash flow statement 6.51B
Levered free cash flow (LFCF) 4.65B
